Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07173270Not ApplicableNot Yet Recruiting

Improved Oral Health in Head and Neck Cancer Survivors

Role: collaborator

NCT04534075Phase 3Completed

Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial

Role: collaborator

NCT05339230Not ApplicableUnknown

Role of Antisecretory Factor in Dihydropyrimidine Treatment of Colorectal Cancer

Role: collaborator

NCT05351931Not ApplicableUnknown

Role of Antisecretory Factor in Curative Radiochemotherapy for Anal Carcinoma

Role: collaborator

All 4 trials loaded